Ignite Creation Date:
2025-12-25 @ 12:57 AM
Ignite Modification Date:
2026-01-02 @ 3:11 PM
Study NCT ID:
NCT05075993
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-02
First Post:
2021-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-12
Start Date Type:
ACTUAL
Primary Completion Date:
2027-02-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02-02
Completion Date Type:
ESTIMATED
First Submit Date:
2021-09-22
First Submit QC Date:
None
Study First Post Date:
2021-10-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-30
Last Update Post Date:
2025-05-02
Last Update Post Date Type:
ACTUAL